eBay
EBAY
Ermenegildo Zegna NV
ZGN
Hutchmed (China)
HCM
4
Collegium Pharmaceutical
COLL
5
Enerpac Tool
EPAC
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -24.02%35.55M | -29.89%7.07M | -37.75%8.43M | -27.17%8.67M | 1.08%11.38M | -18.14%46.79M | -33.15%10.09M | 4.89%13.55M | -8.02%11.9M | -30.58%11.26M |
Net income from continuing operations | 9.97%-34.99M | 72.94%-10.66M | -164.04%-5.88M | -178.54%-6.13M | -91.38%-12.32M | -230.49%-38.87M | -1,454.40%-39.41M | 1,326.09%9.18M | -121.92%-2.2M | -139.74%-6.44M |
Operating gains losses | 702.83%84.88M | 1,922.36%18M | 20.30%5.77M | 5,864.79%15.39M | 786.68%45.73M | 427.74%10.57M | 133.98%890K | 1,453.95%4.79M | ---267K | --5.16M |
Depreciation and amortization | 368.50%4.76M | 176.42%2.24M | 368.45%965K | --770K | --786K | --1.02M | --810K | --206K | --0 | --0 |
Other non cashItems | 30.62%5.09M | 9.06%1.14M | 65.37%1.57M | 144.69%2.26M | -87.44%123K | -45.05%3.9M | -70.73%1.05M | -42.60%950K | -77.61%922K | 143.38%979K |
Change in working capital | 70.49%-5.76M | -422.72%-2.46M | 67.27%-1.42M | 80.51%-1.18M | 91.96%-695K | -29.33%-19.51M | 92.70%-471K | 30.60%-4.34M | -35.17%-6.07M | -511.67%-8.64M |
-Change in payables and accrued expense | 76.12%-345K | -834.88%-316K | 41.18%-420K | -72.99%245K | 108.69%146K | -201.47%-1.45M | -93.87%43K | -325.24%-714K | 22.73%907K | -404.80%-1.68M |
-Change in other current assets | 90.53%-1.88M | 75.89%-237K | 93.82%-197K | 86.53%-955K | 94.28%-493K | -12.48%-19.88M | 87.47%-983K | 59.64%-3.19M | -20.46%-7.09M | -317.82%-8.62M |
-Change in other current liabilities | -294.98%-3.53M | -507.04%-1.91M | -85.22%-802K | -500.00%-472K | -121.00%-348K | 55.85%1.81M | -32.03%469K | -132.41%-433K | -82.12%118K | 208.73%1.66M |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | -24.02%35.55M | -29.89%7.07M | -37.75%8.43M | -27.17%8.67M | 1.08%11.38M | -18.14%46.79M | -33.15%10.09M | 4.89%13.55M | -8.02%11.9M | -30.58%11.26M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 235.72%427.91M | 101.13%172.67M | 354.83%121.53M | -101.53%-295K | 91.29%134.02M | -34.02%127.46M | -66.61%85.85M | -489.43%-47.69M | 111.60%19.24M | -21.88%70.06M |
Net investment purchase and sale | --19.33M | --18.22M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net proceeds payment for loan | 209.17%389.55M | 63.53%140.02M | 341.30%116.47M | -103.80%-722K | 92.09%133.78M | -26.84%126M | -66.55%85.62M | -222.03%-48.27M | 111.02%19M | 42.06%69.65M |
Capital expenditure | ---358K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net other investing changes | 353.11%6.63M | 790.75%2.02M | 583.04%3.95M | 74.29%427K | -43.83%232K | -82.81%1.46M | 100.61%227K | 2.30%578K | -94.39%245K | -98.98%413K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 235.72%427.91M | 101.13%172.67M | 354.83%121.53M | -101.53%-295K | 91.29%134.02M | -34.02%127.46M | -66.61%85.85M | -489.43%-47.69M | 111.60%19.24M | -21.88%70.06M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -147.54%-507.63M | -299.62%-185.79M | -170.34%-128.26M | 11.97%-37.24M | -127.14%-156.34M | -28.43%-205.07M | 77.67%-46.49M | -278.96%-47.44M | -125.67%-42.31M | 51.78%-68.83M |
Net issuance payments of debt | -268.78%-444.25M | -541.17%-171.33M | -323.65%-113.98M | -20.03%-21.19M | -180.06%-137.74M | 36.43%-120.47M | 85.75%-26.72M | -157.03%-26.91M | -122.29%-17.66M | 61.66%-49.18M |
Net commonstock issuance | --0 | --0 | --0 | ---- | ---- | -104.33%-4.6M | --0 | --0 | ---- | ---- |
Cash dividends paid | 21.48%-59.64M | 23.63%-13.81M | 27.99%-13.81M | 28.68%-13.8M | 5.82%-18.22M | -5.78%-75.95M | 5.81%-18.08M | 0.09%-19.18M | -15.57%-19.35M | -16.03%-19.35M |
Net other financing activities | 7.56%-3.74M | 61.18%-656K | 65.76%-465K | -219.89%-2.25M | -24.58%-370K | 12.55%-4.05M | -15.20%-1.69M | 7.37%-1.36M | 32.70%-704K | 54.38%-297K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -147.54%-507.63M | -299.62%-185.79M | -170.34%-128.26M | 11.97%-37.24M | -127.14%-156.34M | -28.43%-205.07M | 77.67%-46.49M | -278.96%-47.44M | -125.67%-42.31M | 51.78%-68.83M |
Net cash flow | ||||||||||
Beginning cash position | -21.81%110.46M | 18.57%72.35M | -50.46%70.65M | -35.28%99.52M | -21.81%110.46M | 179.12%141.28M | -21.06%61.02M | 456.50%142.6M | 1,017.55%153.76M | 179.12%141.28M |
Current changes in cash | -43.30%-44.17M | -112.24%-6.05M | 102.08%1.7M | -158.66%-28.87M | -187.63%-10.94M | -133.99%-30.82M | -22.72%49.44M | -257.89%-81.59M | -194.06%-11.16M | 133.88%12.49M |
End cash position | -39.98%66.29M | -39.98%66.29M | 18.57%72.35M | -50.46%70.65M | -35.28%99.52M | -21.81%110.46M | -21.81%110.46M | -21.06%61.02M | 456.50%142.6M | 1,017.55%153.76M |
Free cash flow | -24.79%35.19M | -33.44%6.71M | -37.75%8.43M | -27.17%8.67M | 1.08%11.38M | -18.14%46.79M | -33.15%10.09M | 4.89%13.55M | -8.02%11.9M | -30.58%11.26M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |